Goldman Sachs trending higher following Q2 earnings report Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Organogenesis (ORGO) up 21% after guiding Q2 revenue above consensus
- Moderna (MRNA) up 14% after
disclosing the publication of updated interim results of its Phase 1 study of mRNA-1273 vaccine against COVID-19
- TherapeuticsMD (TXMD) up 12% after the company and Nurx, an online practice for women's health, announced an arrangement to expand access to Annovera annual birth control ring
UP AFTER EARNINGS -
- Goldman Sachs (GS) up 4%
- PNC FInancial (PNC) up 1%
- U.S. Bancorp (USB) up 3%
- Infosys (INFY) up 11%
DOWN AFTER EARNINGS -
ALSO LOWER -
- Zynex (ZYXI) down 14% after a 2.5M share block trade priced at $22.00 per share
- ASML (ASML) down 1% after agreeing to acquire all shares of Berliner Glas
Symbols:
ORGO TXMD MRNA PNC GS INFY BK ASML ZYXI USB Keywords: Fly Intel, Wall Street, Top Stories, Stocks